Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Omar Roger Kayaleh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5000685866. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial. Co-author DOI 10.1093/oncolo/oyag250↗
  2. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma. Co-author DOI 10.2217/fon-2023-0256↗
  3. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-In… Co-author DOI 10.1016/j.jvir.2019.11.037↗
  4. Transsplenic Microwave Ablation of Pancreatic Adenocarcinoma in a Morbidly Obese Patient. First author DOI 10.1016/j.jvir.2020.02.009↗
  5. A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinom… Co-author DOI 10.1007/s10637-011-9691-8↗
  6. Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy. Co-author DOI 10.2174/092986712801661077↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sherise Chantell Rogers · 2 shared papers, 2023–2026 · strength 0.39
  2. Ryan Michael Thomas · 2 shared papers, 2023–2026 · strength 0.39
  3. Ibrahim Nassour · 2 shared papers, 2023–2026 · strength 0.39
  4. Kathryn E. Hitchcock · 2 shared papers, 2023–2026 · strength 0.39
  5. Jesus C. Fabregas · 2 shared papers, 2023–2026 · strength 0.39
  6. Steven J. Hughes · 2 shared papers, 2023–2026 · strength 0.39
  7. Thomas J. George · 2 shared papers, 2023–2026 · strength 0.39
  8. Béla Kis · 2 shared papers, 2020 · strength 0.35
  9. Z. Hugh Fan · 1 shared paper, 2026 · strength 0.24
  10. Ruchi Singhal · 1 shared paper, 2023 · strength 0.15
  11. Jessica M. Frakes · 1 shared paper, 2020 · strength 0.11
  12. Umesh T. Sankpal · 1 shared paper, 2012 · strength 0.04
  13. Riyaz M. Basha · 1 shared paper, 2012 · strength 0.04
  14. Andrew H. Ko · 1 shared paper, 2012 · strength 0.03
  15. Eric Keith Rowinsky · 1 shared paper, 2012 · strength 0.03
  16. Heinz‐Josef Lenz · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.